Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

Mifepristone Will Remain Accessible and on the Market for the Foreseeable Future 

New Haven, CT — The Supreme Court’s decision to grant the stay requested by the Department of Justice (DOJ) and Danco in Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration et al. means Mifepristone will remain accessible for all residents of Connecticut and Rhode Island for the foreseeable future. The case will now proceed through the Fifth Circuit Court of Appeals and may return on appeal before the Supreme Court.   

Statement from Amanda Skinner, President & CEO of Planned Parenthood of Southern New England:

“While we are relieved that science and commonsense prevailed, we should never be in a position where judges are deciding whether people can get safe, effective medicines. This case’s repercussions go far beyond abortion care — it could stifle medical innovation, upend the country’s drug approval process, and put every approved medication in the political crosshairs. Planned Parenthood of Southern New England will never stop fighting to make sure patients have access to the essential health care that they need.” 

Mifepristone has been used by over five million people since the FDA approved it more than 20 years ago and has significantly expanded access to reproductive health care, something that is clearly under attack in this country. 

Learn more about medication abortion here. For more information about options and a state-by-state guide to get care, go to AbortionFinder.org or call 1-800-230-PLAN. 



This website uses cookies

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of required cookies when utilizing our site; this includes necessary cookies that help our site to function (such as remembering your cookie preference settings). For more information, please see our Privacy Notice.



We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.



We use qualitative data, including session replay, to learn about your user experience and improve our products and services.



We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.